A Two-Part Randomized Study to Evaluate the Relative Bioavailability of Temsavir Following Single Dose Administration of Fostemsavir 600 mg Tablets Compared to Two Fostemsavir 200 mg Tablet Formulations and to Evaluate the Effect of Food on Bioavailability of Selected Fostemsavir 200 mg Tablet Formulation in Healthy Adult Participants
Latest Information Update: 23 Sep 2021
At a glance
- Drugs Fostemsavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
Most Recent Events
- 21 Sep 2021 Status changed from recruiting to completed.
- 25 May 2021 Planned End Date changed from 23 Jul 2021 to 28 Jul 2021.
- 25 May 2021 Planned primary completion date changed from 23 Jul 2021 to 28 Jul 2021.